about
The Centenary of Immune Thrombocytopenia - Part 1: Revising Nomenclature and PathogenesisCD16 and CD32 Gene Polymorphisms May Contribute to Risk of Idiopathic Thrombocytopenic Purpura.Interferon-gamma +874A/T and interleukin-4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura.BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.Raised expression of APRIL in Chinese patients with immune thrombocytopenia and its clinical implications.Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with idiopathic thrombocytopenic purpura in a Chinese population.Pathophysiology and therapeutic options in primary immune thrombocytopenia.The levels of IL-17A and of the cytokines involved in Th17 cell commitment are increased in patients with chronic immune thrombocytopenia.Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia.Bmi-1 regulates autoreactive CD4+ T cell survival in immune thrombocytopenia patients.Role of DNA methyltransferase 3A mRNA expression in Egyptian patients with idiopathic thrombocytopenic purpura.Transplantation of adipose-derived mesenchymal stem cells into a murine model of passive chronic immune thrombocytopenia.DNA methyltransferase 3B gene promoter and interleukin-1 receptor antagonist polymorphisms in childhood immune thrombocytopenia.PTPN22 -1123G > C polymorphism is associated with susceptibility to primary immune thrombocytopenia in Chinese population.Lack of impact of cytotoxic T-lymphocyte antigen 4 gene exon 1 polymorphism on susceptibility to or clinical course of egyptian childhood immune thrombocytopenic purpura.In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitorElevated NKT cell levels in adults with severe chronic immune thrombocytopenia.Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).Absence of association of interleukin-18 gene polymorphisms with primary immune thrombocytopenia in a Chinese Han population.Cytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication.STAT1 single nucleotide polymorphisms and susceptibility to immune thrombocytopenia.A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia.The effect of single course high dose dexamethasone on CD28/CTLA-4 balance in the treatment of patients with newly diagnosed primary immune thrombocytopenia.Stromal cell-derived factor-1 rs2297630 polymorphism associated with platelet production and treatment response in Chinese patients with chronic immune thrombocytopenia.Increased susceptibility to infections before the diagnosis of immune thrombocytopenia.Abnormal Distribution and Function of Monocyte Subsets in Patients With Primary Immune Thrombocytopenia.Decreased TLR4 expression on monocytes may cause regulatory T cells abnormality in patients with primary immune thrombocytopenia.Is There a Relationship Between CXCR4 Gene Expression and Prognosis of Immune Thrombocytopenia in Children?Expression of CD markers' in immune thrombocytopenic purpura: prognostic approaches.The potential association of tumor necrosis factor-βeta (252 G/A) cytokine gene polymorphism with immune thrombocytopenic purpura among Egyptian children.
P2860
Q28068881-D20C8676-AF47-4A9B-8098-275988DDCFABQ30249541-980BF25E-1C9F-42AE-9A40-DC61CF8820E5Q33376005-713CEA75-D269-4B9C-B924-FE1F860C3FAEQ33381985-21FEBF4C-3788-46AC-9DB5-4262DCEB2C8DQ33386608-85378A2D-8468-49A3-A03E-022E72D4FF75Q33390753-3E3F8CFD-CB5B-4D7C-9245-EF9EEA4891A7Q33392564-BF81C648-DD03-4A5A-86F2-C652A7C43E49Q33393732-1738EB03-4AE3-4DCD-93FC-C69011626536Q33397483-F301E1B8-829E-4D7B-B222-B199502B87EDQ33399044-B7BAAF9F-F984-4D69-89F0-F7BF8CC13B5AQ33399426-9394DC39-3438-486C-A4C6-37FCFADA6AC3Q33399617-7A09379E-D01B-4D9A-B2D6-F6C58B441BC6Q33400635-F0652527-F910-46AF-8FA5-F0C4D383DA39Q33403731-15E7E77E-66E3-413E-8358-26389F276C22Q33404016-B079839A-083B-4B89-A673-A18789BBAD8CQ33410250-FDF2C96F-6E15-4B58-9011-1B3F87D74293Q33412076-20F22F5F-C8A1-4939-A6D8-FE5661501AB4Q33412177-D2AFA73A-229B-449F-984E-B68FBEA4EBABQ33412876-F4022CA9-05AF-4486-A99F-3043F7AD8FDBQ33414676-A06256BD-A88C-4855-A217-2CC083E29DA5Q33417859-7DF076E8-4865-4020-9BD7-F549AB3678D0Q33420638-9D82D2FA-7FA4-4A06-82AA-13FF1545AFBDQ33421329-C63BBF4C-6D90-40C9-8A96-73F8CCB256CAQ33424754-2CCAC1DA-BD35-44EC-BFCA-CBE84355E7A8Q33427702-AB9DF084-3172-44D9-9EB6-3FA4A2226752Q33429368-97CAF804-4565-4538-8EA2-FD3606D705BFQ33433318-99F8B55A-D270-4B51-A89A-F9099AC55ADCQ33441020-E37249C2-6A02-48DE-9381-EE406C16A143Q33442558-59E4EF37-44D0-4BE4-8AC3-7234566B3817Q47727224-39CFF23C-BFFE-440F-B4A6-201E85C979BCQ48208737-ED001ADE-0B15-444E-A30C-801586B34AB8
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Multi-dysfunctional pathophysiology in ITP.
@ast
Multi-dysfunctional pathophysiology in ITP.
@en
type
label
Multi-dysfunctional pathophysiology in ITP.
@ast
Multi-dysfunctional pathophysiology in ITP.
@en
prefLabel
Multi-dysfunctional pathophysiology in ITP.
@ast
Multi-dysfunctional pathophysiology in ITP.
@en
P50
P1476
Multi-dysfunctional pathophysiology in ITP
@en
P2093
Ren Chi Yang
P304
P356
10.1016/J.CRITREVONC.2004.12.004
P577
2005-05-01T00:00:00Z